About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Malladi Drugs and Pharmaceuticals in Malaysia

by Rajashri on October 11, 2008 at 5:05 PM
Font : A-A+

 Malladi Drugs and Pharmaceuticals in Malaysia

In keeping with the global trend and looking toward Asia, Malladi Drugs and Pharmaceuticals Ltd plans to make substantial investment over the next 3-5 years to set up its global "one-stop shop" in Malaysia.

Malladi Drugs handed over a business plan to Malaysian Biotechnology Corp (Biotech), on the first day of the BioMalaysia 2008 conference and exhibition in the presence of the Malaysian Prime Minister Datuk Seri Abdullah Ahmad Badawi.

Advertisement

According to the plan, the firm aims to expand into other areas of service offering as a contract research organisation in Malaysia including oncology and steroids, and beta-lactums.

Prashant Malladi, Managing Director, Malladi Drugs and Pharmaceuticals Ltd said, "We have been studying this model for some time and are convinced that Malladi is positioned perfectly to deliver this."
Advertisement

BioTech's chief executive officer, Datuk Iskandar Mizal Mahmood, said the firm has yet to pick a site, but would be encouraged to locate at one of the economic corridors in the country, in line with Prime Minister Datuk Seri Abdullah Ahmad Badawi's call for those areas to be driven by biotechnology.

"The investment entails the development of the entire value chain within the contract manufacturing facility starting from the API formulation," he said.

Biotech, one of the main organisers of BioMalaysia, is the lead agency for the biotechnology industry in Malaysia.

Malladi Drugs and Pharmaceutical Ltd is an API manufacturer based out of Chennai, India. The Company has a strong footing and experience in Research and Development and manufacturing of API with a deep rooted experience of more than 50 years. The company intends to expand its service base in the value chain providing the concept of "One-Stop-Shop".

As part of the expansion plan, Malladi intends to establish a Malaysian entity. This entity will serve as a foot-print for the company in the next few stages of the value chain like Formulation R andD, Manufacturing, and Formulation Clinicals. The company also intends to extend its expertise in Oncology and Steroids and in Beta-lactums.

Source: ANI
RAS/SK
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Is COVID-19 Vaccination during Pregnancy Safe?
Sensory Processing Disorder (SPD)
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Drugs Banned in India 

Recommended Reading
Liver Cancer - Animation
Liver is the largest organ inside the human body. It performs 500 different functions and processes ...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use